Phreesia Inc. PHR shares slipped Friday despite a stronger-than-expected second quarter. The healthcare software firm posted earnings of 1 cent per share, topping forecasts for a 6 cent loss, while revenue rose 15% year-over-year to $117.26 million, ahead of estimates. Phreesia's average number of healthcare service clients climbed 7% to 4,467, with revenue per client also up 7% to $26,249. Adjusted EBITDA surged to $22.1 million from $6.5 million a year earlier.Acquisition: Phreesia also announced a $160 m ...

HEALWELL Reports Record Revenue Growth of 645% in Q2-2025 and Achieves First Quarter of Positive Adjusted EBITDA August 13, 2025 6:00 AM EDT | Source: HEALWELL AI Toronto, Ontario--(Newsfile Corp. - August 13, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce its unaudited interim condensed consolidated financial results for the quarter ended June 30, 2025. A summary of the Comp ...

Financial Data and Key Metrics Changes - In Q2 2025, GAAP net income was $4,600,000 or $0.22 per diluted share, up from $3,400,000 or $0.17 per diluted share in Q2 2024 [25] - Total GAAP revenue increased to $35,700,000 from $34,000,000 in the prior year [26] - Adjusted EBITDA for Q2 2025 was $7,500,000 compared to $7,000,000 in the prior year [30] Business Line Data and Key Metrics Changes - Software operations bookings grew by over 34% year-over-year, reaching $11,700,000 in Q2 2025 [11] - Software revenue increased by 10%, with license revenue showing double-digit growth and managed services revenue experiencing triple-digit growth [11] - Wireless revenue was $18,400,000, with a net unit churn improvement to 1.6% from 2.1% in the prior quarter [26] Market Data and Key Metrics Changes - The company maintains a blue-chip customer base of over 2,200 hospitals, with more than 80% of revenue being recurring [20] - The average revenue per unit (ARPU) increased by $0.36 or nearly 5% year-over-year, driven by pricing actions and new product sales [26] Company Strategy and Development Direction - The company aims for double-digit full-year software bookings growth relative to 2024, supported by ongoing investments in technology and sales [5] - The strategic focus remains on generating cash and returning capital to stockholders while investing in business growth [7] - The company is exploring opportunities to integrate AI into its products and operating platform [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the competitive positioning and long-term relationships with healthcare systems [6] - The outlook for the remainder of 2025 is optimistic, with increased guidance for revenue and adjusted EBITDA [12] - The company anticipates annual free cash flow in the range of $25,000,000 to $29,000,000 [33] Other Important Information - The company reported a one-time gain of approximately $700,000 from the sale of a legacy domain name [31] - Cash and cash equivalents at the end of Q2 2025 were $20,200,000, expected to grow through the remainder of the year [32] Q&A Session Summary Question: Impact of increased fees for unreturned pagers on net unit churn - Management indicated that the price increase for unreturned equipment would not impact unit churn as it applies after disconnection [42][44] Question: Progress of the business development team focused on new logos - The business development team has been successful in adding smaller accounts, with ongoing efforts to build the pipeline [49][50] Question: Breakdown of software bookings between new customer acquisitions and expansions - Approximately 15% of software bookings were related to new logos, with ongoing efforts to increase this percentage [51][52]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 reached $271 million, representing a 15% year-over-year growth with an adjusted EBITDA margin of 42% [10][24] - Adjusted EBITDA for Q2 2025 was $113 million, an increase of 20% year-over-year, driven by revenue growth and a shift to higher margin provider solutions [26][30] - The company raised its full-year revenue guidance to a range of $1.03 billion to $1.042 billion, reflecting a 10% year-over-year growth [29] Business Line Data and Key Metrics Changes - Subscription revenue increased to $131 million, up 17% year-over-year, while volume-based revenue reached $138 million, a 14% increase year-over-year [25] - The number of clients generating more than $100,000 in trailing twelve-month revenue increased to 1,268, a 14% year-over-year growth [15] Market Data and Key Metrics Changes - The company noted a strong demand for its AI-powered software platform as providers face margin pressures and workforce shortages [10][12] - Waystar's net revenue retention rate was 115%, benefiting from rapid onboarding of clients affected by a competitor's cyber event [24] Company Strategy and Development Direction - The acquisition of Iodine Software is expected to expand Waystar's total addressable market by over 15% and enhance its product roadmap [6][7] - Waystar aims to lead in the revenue cycle management space by leveraging AI to improve efficiency and reduce administrative burdens for healthcare providers [20][22] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's resilience against potential Medicaid funding cuts, estimating less than a 1% impact on revenue from a hypothetical 15% reduction in Medicaid funding [12][85] - The demand environment remains robust, with providers prioritizing technology that enhances efficiency and cash flow [51][52] Other Important Information - Waystar was recognized as the best overall healthcare payments solution provider by MedTech Breakthrough and named one of the U.S. News Best Companies to Work For [22][23] - The company has established a strong governance structure with the addition of two new independent board members [23] Q&A Session Summary Question: Impact of client migration post-cyber attack on Q2 revenue - Management indicated that the year-over-year benefit from client migration had normalized by Q2, with no significant impact noted [34][36] Question: Recurring nature of volume-based revenue from large clients - Management expects that volume-based revenue from newly onboarded large clients will transition to subscription revenue as contracts mature [45][46] Question: Drivers behind the sequential increase in subscription revenue - The increase in subscription revenue was attributed to strong performance in provider solutions, which comprise a significant portion of total revenue [50][55] Question: Volume growth and digital payment penetration - Management noted that higher utilization in the healthcare system and the adoption of digital payment solutions contributed to volume growth, with a good mix from both patient payment and provider solutions [58][61] Question: Competitive landscape and client demand - Management reported strong win rates against competitors and noted an increase in client demand for AI-driven solutions [106]

Acquisition Overview - Waystar is set to acquire Iodine Software for a total enterprise value of $1.25 billion [7] - Iodine shareholders will own approximately 8% of Waystar on a fully diluted, pro forma basis [9] - Advent, Iodine's largest shareholder, is expected to receive 100% of its transaction consideration in Waystar common stock [9] Strategic Rationale - The acquisition aims to simplify healthcare payments and accelerate AI-powered transformation [5] - It expands Waystar's total addressable market by more than 15% [5] - The deal integrates clinical intelligence software to prevent denials and ensure optimal reimbursement [5] Financial Impact - Iodine's profile includes approximately 99% revenue derived from software subscriptions [26] - Iodine's gross margin is approximately 75% [26] - Iodine's Adjusted EBITDA margin is approximately 40% [26] Q2 2025 Preliminary Results - Waystar's approximate Q2 2025 revenue is $271 million [31] - Waystar's approximate year-over-year growth is 15% [32]

Core Insights - symplr has acquired Smart Square scheduling software from AMN Healthcare, enhancing its healthcare workforce and operations management capabilities [1][2] - The acquisition strengthens the symplr Operations Platform by integrating AI-driven scheduling and workforce management solutions [2][3] - symplr aims to empower healthcare organizations with actionable data and technology to improve efficiencies and patient outcomes [3][4] Company Overview - symplr is a leader in enterprise healthcare operations software, trusted by 9 out of 10 U.S. hospitals and over 400 U.S. health plans [6] - AMN Healthcare is recognized for its total talent solutions in healthcare, reaching nearly 15 million patients across more than 2,100 healthcare systems in 2024 [7] - Clearlake Capital Group and Charlesbank Capital Partners are the backing investment firms for symplr, with Clearlake managing over $90 billion in assets [9][10] Strategic Implications - The acquisition of Smart Square is expected to enhance symplr's offerings in workforce planning, analytics, and AI, addressing the complexities of healthcare staffing [5] - The partnership between symplr and AMN Healthcare aims to combine operational technology expertise with workforce solutions, benefiting customers [4][5] - The integration of Smart Square's AI capabilities is positioned to help healthcare organizations anticipate staffing needs and streamline operations [3][4]

Study finds AI is delivering double-digit gains in revenue cycle performance, becoming indispensable to healthcare providers' success Key findings include: Based on responses from more than 300 healthcare leaders, the study shows that providers are prioritizing strategic AI implementation, especially in payer-facing workflows such as prior authorizations and denial appeals. The research points to a broader shift as AI delivers measurable impact across organizations of all sizes, accelerating automation, enh ...

Financial Data and Key Metrics Changes - Revenues for the first quarter were $73.5 million, up 1% year-over-year [38] - Operating income decreased by 23.1% to $4.4 million [38] - Net income was $4.3 million, down 17.1% [38] - EPS decreased from $0.17 to $0.14 [38] - Adjusted EBITDA was $16.2 million, down 5% [38] Business Line Data and Key Metrics Changes - Credential Stream revenue grew by 25% year-over-year [41][54] - Shift Wizard revenue increased by 19% [41][52] - Competency Suite revenue rose by 12% [41] - Core business, excluding legacy products and customer bankruptcy impacts, grew over 6% [41] Market Data and Key Metrics Changes - Remaining performance obligations were $613 million, up from $514 million year-over-year [42] - Gross margin decreased to 65.3% from 66.2% [42] - Days sales outstanding improved to 37 days from 46 days year-over-year [44] Company Strategy and Development Direction - The company is focused on developing, credentialing, and scheduling the healthcare workforce through SaaS solutions [30] - Emphasis on the interoperability of core applications through the hStream platform [30] - The company aims to bundle value to address mandatory requirements in healthcare [75] Management's Comments on Operating Environment and Future Outlook - Management acknowledged macroeconomic headwinds affecting purchasing decisions, particularly for elective content [9][10] - Despite challenges, management remains optimistic about revenue and EBITDA growth year-over-year [8] - Revised guidance reflects a cautious outlook due to delays in medium-sized deals and technology scaling issues [26][36] Other Important Information - The company has a strong cash balance of $113.3 million and no interest-bearing debt [33][44] - A quarterly cash dividend of $0.031 per share was declared [48] - The company maintains an active pipeline for potential acquisitions [47] Q&A Session Summary Question: How much of the portfolio is required versus elective? - Management indicated that the majority of products are tied to some form of requirement, estimating around 80% to 90% [80][86] Question: Was the largest contract a renewal or new business? - The largest contract was new business, involving a significant health system that had not previously used the company's learning management system [90][91] Question: What is the status of legacy products? - Legacy products are still supported but not actively sold, with a focus on transitioning customers to newer solutions [100]

Company Overview - Waystar is a provider of healthcare payment software, aiming to simplify healthcare payments for providers to enhance patient care and financial performance [3] - The company serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of the top 20 institutions on the U.S. News Best Hospitals list [3] - Waystar's platform processes over 6 billion healthcare payment transactions annually, amounting to over $1.8 trillion in gross claims, covering approximately 50% of U.S. patients [3] Upcoming Events - CFO Steve Oreskovich will present at the Bank of America Securities Healthcare Conference on May 14, 2025, at 8:40 a.m. PT [2] - CEO Matt Hawkins will present at the William Blair 45th Annual Growth Stock Conference on June 3, 2025, at 12 p.m. CT [2] - Both presentations will be streamed live on Waystar's Investor Relations website, with recordings available afterward [2]